Websites
-
McKeating Lab Website
Click above to visit our lab website.
-
McKeating TDI Website
Click above to visit our TDI website.
Jane McKeating
Professor of Molecular Virology
McKeating Group
Viruses are intracellular pathogens and understanding host pathways that define susceptibility to infection and disease are essential for the design of new therapies. Viral replication is shaped by the cellular microenvironment and current projects focus on the spatial mapping of infected cells at single-cell resolution to identify the key factors that regulate virus tissue tropism.
RESEARCH THEMES
Hepatitis viruses
Chronic hepatitis B and D viruses are a major cause of liver disease and cancer, with limited curative treatments. The liver is a naturally hypoxic organ and we have identified a role for hypoxia inducible factors to activate viral transcription. Our goal is to understand the hepatocyte-intrinsic and extrinsic pathways that define host susceptibility to these viruses. The frequency of infected cells in the liver is low and bulk RNA-sequencing approaches frequently overlook their complex transcriptomes. We have developed spatial transcriptional profiling methods to identify HBV and HDV infected hepatocytes and their uninfected neighbours. When combined with single molecule resolution imaging of viral RNAs, these exciting technologies allow us to study virus-host interplay at unprecedented detail.
Respiratory viruses
Globally respiratory infections are responsible for approximately 4.25 million deaths/year (pre-COVID), mostly in children and the elderly. Viruses are responsible for the majority of these infections and developing broadly active tools to fight these viruses is a priority. We have shown that hypoxia suppresses SARS-CoV-2 replication and inflammatory responses. We have recently extended these observations to Respiratory Syncytial virus and shown our HIF mimetic drugs potently inhibit infection by activating innate sensing and Interferon-signalling.
Research Funding
The McKeating lab are delighted to be amongst the recipients of a Wellcome Trust Discovery Award together with additional funding from the Medical Research Council and the Chinese Academy of Medical Science Oxford Institute. We aim to deliver an ambitious programme of research, applying cutting edge spatial technologies to study the mechanisms of persistence in both acute and chronic viral infection. We are excited to announce that we are welcoming applications for funded post-doctoral research positions.
Key publications
Long-persisting SARS-CoV-2 spike-specific CD4+ T cells associated with mild disease and increased cytotoxicity post COVID-19
Journal article
Liu G. et al, (2025), Nature Communications, 16
Episomal and integrated hepatitis B transcriptome mapping uncovers heterogeneity with the potential for drug-resistance
Journal article
Harris JM. et al, (2025), Nature Communications, 16
ssessing the virological response to direct-acting antiviral therapies in the HBV cure programme.
Journal article
Lok J. et al, (2025), Virology, 605
Characterisation of HBV and co-infection with HDV and HIV through spatial transcriptomics
Journal article
Cross A. et al, (2024), eGastroenterology, 2, e100067 - e100067
Oxygen-dependent histone lysine demethylase 4 restricts hepatitis B virus replication
Journal article
Harris JM. et al, (2024), Journal of Biological Chemistry, 300, 105724 - 105724
Hypoxia inducible factors inhibit respiratory syncytial virus infection by modulation of nucleolin expression.
Journal article
Zhuang X. et al, (2024), iScience, 27
Recent publications
Long-persisting SARS-CoV-2 spike-specific CD4+ T cells associated with mild disease and increased cytotoxicity post COVID-19
Journal article
Liu G. et al, (2025), Nature Communications, 16
Episomal and integrated hepatitis B transcriptome mapping uncovers heterogeneity with the potential for drug-resistance
Journal article
Harris JM. et al, (2025), Nature Communications, 16
Use of polyethylene glycol precipitation and ultracentrifugation to enhance the sensitivity of hepatitis B virus DNA detection
Journal article
Fu MX. et al, (2025), Journal of Clinical Virology, 178, 105802 - 105802
ssessing the virological response to direct-acting antiviral therapies in the HBV cure programme.
Journal article
Lok J. et al, (2025), Virology, 605
Novel Toolkit of SARS-CoV-2 Sub-Genomic Replicons for Efficient Antiviral Screening.
Journal article
Erdmann M. et al, (2025), Viruses, 17
bsolute quantitative and base-resolution sequencing reveals comprehensive landscape of pseudouridine across the human transcriptome
Journal article
Xu H. et al, (2024), Nature Methods, 21, 2024 - 2033
Characterisation of HBV and co-infection with HDV and HIV through spatial transcriptomics
Journal article
Cross A. et al, (2024), eGastroenterology, 2, e100067 - e100067
n atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infection
Journal article
Mukherji A. et al, (2024), Nature Communications, 15
Oxygen-dependent histone lysine demethylase 4 restricts hepatitis B virus replication
Journal article
Harris JM. et al, (2024), Journal of Biological Chemistry, 300, 105724 - 105724
Hypoxia inducible factors inhibit respiratory syncytial virus infection by modulation of nucleolin expression.
Journal article
Zhuang X. et al, (2024), iScience, 27
CTCF regulates hepatitis B virus cccDNA chromatin topology.
Journal article
Dobrica MO. et al, (2024), The Journal of general virology, 105
The N6-methyladenosine demethylase ALKBH5 regulates the hypoxic HBV transcriptome.
Journal article
Tsukuda S. et al, (2024), PLoS pathogens, 20
SPP2 binds to hepatitis C virus NS5A protein via an SH3 domain/PxxP motif-mediated interaction and potentiates infection
Journal article
Smirnov A. et al, (2023), Journal of General Virology, 104
Hypoxia dampens innate immune signalling at early time points and increases Zika virus RNA levels in iPSC-derived macrophages
Journal article
Schilling M. et al, (2023), Journal of General Virology, 104
Inhibition of salt inducible kinases reduces rhythmic HIV-1 replication and reactivation from latency.
Journal article
Borrmann H. et al, (2023), The Journal of general virology, 104
Molecular components of the circadian clock regulate HIV-1 replication.
Journal article
Borrmann H. et al, (2023), iScience, 26
HLA-E–restricted SARS-CoV-2–specific T cells from convalescent COVID-19 patients suppress virus replication despite HLA class Ia down-regulation
Journal article
Yang H. et al, (2023), Science Immunology, 8
n enrichment protocol and analysis pipeline for long read sequencing of the hepatitis B virus transcriptome
Journal article
Ng E. et al, (2023), Journal of General Virology, 104
n ACAT inhibitor suppresses SARS-CoV-2 replication and boosts antiviral T cell activity
Journal article
Wing PAC. et al, (2023), PLOS Pathogens, 19, e1011323 - e1011323
Sleep and circadian rhythm disruption alters the lung transcriptome to predispose to viral infection.
Journal article
Taylor L. et al, (2023), iScience, 26
Hypoxia dampens innate immune signalling at early time points and increases Zika virus replication in iPSC-derived macrophages
Preprint
Schilling M. et al, (2023)
Circadian regulation of human immunodeficiency virus type 1 replication
Preprint
Borrmann H. et al, (2022)
Hypoxia inducible factors regulate infectious SARS-CoV-2, epithelial damage and respiratory symptoms in a hamster COVID-19 model
Journal article
Wing PAC. et al, (2022), PLOS Pathogens, 18, e1010807 - e1010807
Time-of-Day Variation in SARS-CoV-2 RNA Levels during the Second Wave of COVID-19
Journal article
Zhuang X. et al, (2022), Viruses, 14, 1728 - 1728
e the Patterns of Cytomegalovirus Viral Load Seen After Solid Organ Transplantation Affected by Circadian Rhythm?
Journal article
Rafferty H. et al, (2022), The Journal of infectious diseases, 226, 357 - 365
Reply to: ‘Active HBV replication in hypoxic pericentral zone 3 is upregulated by multiple host factors including HIF-1α’
Journal article
Harris JM. et al, (2022), Journal of Hepatology, 77, 267 - 268
Inflammatory Gene Expression Associates with Hepatitis B Virus cccDNA- but Not Integrant-Derived Transcripts in HBeAg Negative Disease
Journal article
Magri A. et al, (2022), Viruses, 14, 1070 - 1070
Hypoxia inducible factors regulate infectious SARS-CoV-2, epithelial damage and respiratory symptoms in a hamster COVID-19 model
Preprint
Wing PAC. et al, (2022)
The role of circadian clock pathways in viral replication.
Journal article
Zhuang X. et al, (2022), Seminars in immunopathology, 44, 175 - 182
Time of Day of Vaccination Affects SARS-CoV-2 Antibody Responses in an Observational Study of Health Care Workers
Journal article
Wang W. et al, (2022), Journal of Biological Rhythms, 37, 124 - 129
bsolute quantitation of individual SARS-CoV-2 RNA molecules provides a new paradigm for infection dynamics and variant differences
Journal article
Lee JY. et al, (2022), eLife, 11
n immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease
Journal article
Peng Y. et al, (2022), Nature Immunology, 23, 50 - 61
Direct RNA sequencing of respiratory syncytial virus infected human cells generates a detailed overview of RSV polycistronic mRNA and transcript abundance.
Journal article
Donovan-Banfield I. et al, (2022), PloS one, 17
Time of day of vaccination affects SARS-CoV-2 antibody responses in an observational study of healthcare workers
Preprint
Wang W. et al, (2021)
Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failure
Journal article
Smith DA. et al, (2021), Nature Communications, 12
The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells
Journal article
Zhuang X. et al, (2021), iScience, 24, 103144 - 103144
Hypoxia-Inducible Factor 1 Alpha-Mediated RelB/APOBEC3B Down-regulation Allows Hepatitis B Virus Persistence.
Journal article
Riedl T. et al, (2021), Hepatology (Baltimore, Md.), 74, 1766 - 1781
Supramolecular Cylinders Target Bulge Structures in the 5' UTR of the RNA Genome of SARS-CoV-2 and Inhibit Viral Replication.
Journal article
Melidis L. et al, (2021), Angewandte Chemie (Weinheim an der Bergstrasse, Germany), 133, 18292 - 18299
Supramolecular Cylinders Target Bulge Structures in the 5' UTR of the RNA Genome of SARS-CoV-2 and Inhibit Viral Replication*.
Journal article
Melidis L. et al, (2021), Angewandte Chemie (International ed. in English), 60, 18144 - 18151
Hypoxia inducible factors regulate hepatitis B virus replication by activating the basal core promoter
Journal article
Wing PAC. et al, (2021), Journal of Hepatology, 75, 64 - 73
bsolute quantitation of individual SARS-CoV-2 RNA molecules: a new paradigm for infection dynamics and variant differences
Journal article
Lee JY. et al, (2021)
Targeting human Acyl-CoA:cholesterol acyltransferase as a dual viral and T cell metabolic checkpoint
Journal article
Schmidt NM. et al, (2021), Nature Communications, 12
Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells
Journal article
Wing PAC. et al, (2021), Cell Reports, 35, 109020 - 109020
Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment.
Journal article
Ohashi H. et al, (2021), iScience, 24
The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells
Journal article
Zhuang X. et al, (2021)
Circadian control of hepatitis B virus replication
Journal article
Zhuang X. et al, (2021), Nature Communications, 12
PCR assay to quantify patterns of HBV transcription
Journal article
D’Arienzo V. et al, (2021), Journal of General Virology, 102
The CCCTC ‐binding factor CTCF represses hepatitis B virus enhancer I and regulates viral transcription
Journal article
D'Arienzo V. et al, (2021), Cellular Microbiology, 23
The Circadian Clock and Viral Infections.
Journal article
Borrmann H. et al, (2021), Journal of biological rhythms, 36, 9 - 22
Clocks, Viruses, and Immunity: Lessons for the COVID-19 Pandemic.
Journal article
Sengupta S. et al, (2021), Journal of biological rhythms, 36, 23 - 34
Estimating hepatitis B virus cccDNA persistence in chronic infection†
Journal article
Lythgoe KA. et al, (2021), Virus Evolution, 7
Role for B Cells to Transmit Hepatitis C Virus Infection.
Journal article
Desombere I. et al, (2021), Frontiers in immunology, 12
ccurate targeted long-read DNA methylation and hydroxymethylation sequencing with TAPS
Journal article
Liu Y. et al, (2020), Genome Biology, 21
Synchronised infection identifies early rate-limiting steps in the hepatitis B virus life cycle.
Journal article
Chakraborty A. et al, (2020), Cellular microbiology, 22
Correction: Hypoxic gene expression in chronic hepatitis B virus infected patients is not observed in state-of-the-art in vitro and mouse infection models
Journal article
Liu PJ. et al, (2020), Scientific Reports, 10
Oxygen Sensing and Viral Replication: Implications for Tropism and Pathogenesis
Journal article
Liu PJ. et al, (2020), Viruses, 12, 1213 - 1213
Hypoxic gene expression in chronic hepatitis B virus infected patients is not observed in state-of-the-art in vitro and mouse infection models
Journal article
Liu PJ. et al, (2020), Scientific Reports, 10
Pharmacological activation of the circadian component REV-ERB inhibits HIV-1 replication
Journal article
Borrmann H. et al, (2020), Scientific Reports, 10
Cholesterol-modifying drugs in COVID-19
Journal article
Schmidt NM. et al, (2020), Oxford Open Immunology, 1
Hypoxic microenvironment shapes HIV-1 replication and latency
Journal article
Zhuang X. et al, (2020), Communications Biology, 3
Estimating hepatitis B virus cccDNA persistence in chronic infection
Journal article
Lythgoe KA. et al, (2020)
Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimize Treatment Outcome in Genotype 1 Noncirrhotic Treatment-Naïve Patients With Chronic Hepatitis C Virus
Journal article
Fawsitt CG. et al, (2020), Value in Health, 23, 180 - 190
Interferon lambda 4 impacts the genetic diversity of hepatitis C virus
Journal article
Ansari MA. et al, (2019), eLife, 8
Cost-Effectiveness Analysis of Shortened Direct-Acting Antiviral Treatment in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus
Journal article
Fawsitt CG. et al, (2019), Value in Health, 22, 693 - 703
Bacterial flagellin promotes viral entry via an NF-kB and Toll Like Receptor 5 dependent pathway.
Journal article
Benedikz EK. et al, (2019), Scientific reports, 9
dual role for SAMHD1 in regulating HBV cccDNA and RT-dependent particle genesis
Journal article
Wing PAC. et al, (2019), Life Science Alliance, 2, e201900355 - e201900355
Hepatitis C virus infection is associated with hepatic and adipose tissue insulin resistance that improves after viral cure
Journal article
Lim TR. et al, (2019), Clinical Endocrinology, 90, 440 - 448
The circadian clock components BMAL1 and REV-ERBα regulate flavivirus replication
Journal article
Zhuang X. et al, (2019), Nature Communications, 10
Insights From Deep Sequencing of the HBV Genome—Unique, Tiny, and Misunderstood
Journal article
McNaughton AL. et al, (2019), Gastroenterology, 156, 384 - 399
Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels
Journal article
Ko C. et al, (2018), Journal of Hepatology, 69, 1231 - 1241
Glucose and glutamine availability regulate HepG2 transcriptional responses to low oxygen
Journal article
Lai AG. et al, (2018), Wellcome Open Research, 3, 126 - 126
Daytime variation in hepatitis C virus replication kinetics following liver transplant
Journal article
Zhuang X. et al, (2018), Wellcome Open Research, 3, 96 - 96
Metallo supramolecular cylinders inhibit HIV-1 TAR-TAT complex formation and viral replication in cellulo
Journal article
Cardo L. et al, (2018), Scientific Reports, 8
Correction to ‘Viral hepatitis and liver cancer’
Journal article
Ringelhan M. et al, (2018), Philosophical Transactions of the Royal Society B: Biological Sciences, 373
Daytime variation in hepatitis C virus replication kinetics following liver transplant
Preprint
Zhuang X. et al, (2018)
Interplay between circadian clock and viral infection
Journal article
Zhuang X. et al, (2017), Journal of Molecular Medicine, 95, 1283 - 1289
Viral hepatitis and liver cancer
Journal article
Ringehan M. et al, (2017), Philosophical Transactions of the Royal Society B: Biological Sciences, 372, 20160274 - 20160274
Glucocorticoids promote Von Hippel Lindau degradation and Hif-1α stabilization
Journal article
Vettori A. et al, (2017), Proceedings of the National Academy of Sciences, 114, 9948 - 9953
new panel of epitope mapped monoclonal antibodies recognising the prototypical tetraspanin CD81
Journal article
Grove J. et al, (2017), Wellcome Open Research, 2, 82 - 82
Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus
Journal article
Ansari MA. et al, (2017), Nature Genetics, 49, 666 - 673
axin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication
Journal article
Farquhar MJ. et al, (2017), Journal of Hepatology, 66, 919 - 929
The Measles Virus Receptor SLAMF1 Can Mediate Particle Endocytosis
Journal article
Gonçalves-Carneiro D. et al, (2017), Journal of Virology, 91
TNF superfamily members promote hepatitis C virus entry via an NF-κB and myosin light chain kinase dependent pathway
Journal article
Fletcher NF. et al, (2017), Journal of General Virology, 98, 405 - 412
N-Glycosylation of the Na+-Taurocholate Cotransporting Polypeptide (NTCP) Determines Its Trafficking and Stability and Is Required for Hepatitis B Virus Infection
Journal article
Appelman MD. et al, (2017), PLOS ONE, 12, e0170419 - e0170419
High resolution sequencing of hepatitis C virus reveals limited intra-hepatic compartmentalization in end-stage liver disease
Journal article
Hedegaard DL. et al, (2017), Journal of Hepatology, 66, 28 - 38
Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of Hepatocytes
Journal article
Verrier ER. et al, (2016), Cell Reports, 17, 1357 - 1368
Deep sequencing of hepatitis C virus reveals genetic compartmentalization in cerebrospinal fluid from cognitively impaired patients
Journal article
Tully DC. et al, (2016), Liver International, 36, 1418 - 1424
Comprehensive Analysis of the Impact of HIV on HCV Immune Responses and Its Association with Liver Disease Progression in a Unique Plasma Donor Cohort
Journal article
Zhang Y-H. et al, (2016), PLOS ONE, 11, e0158037 - e0158037
MAIT cells are activated during human viral infections
Journal article
van Wilgenburg B. et al, (2016), Nature Communications, 7
Monoclonal anti‐envelope antibody AP33 protects humanized mice against a patient‐derived hepatitis C virus challenge
Journal article
Desombere I. et al, (2016), Hepatology, 63, 1120 - 1134
Effect of scavenger receptor class B type I antagonist ITX5061 in patients with hepatitis C virus infection undergoing liver transplantation
Journal article
Rowe IA. et al, (2016), Liver Transplantation, 22, 287 - 297
Lentiviral hepatitis B pseudotype entry requires sodium taurocholate co-transporting polypeptide and additional hepatocyte-specific factors
Journal article
Meredith LW. et al, (2016), Journal of General Virology, 97, 121 - 127
daptive Mutations Enhance Assembly and Cell-to-Cell Transmission of a High-Titer Hepatitis C Virus Genotype 5a Core-NS2 JFH1-Based Recombinant
Journal article
Mathiesen CK. et al, (2015), Journal of Virology, 89, 7758 - 7775
Permissivity of primary hepatocytes and hepatoma cell lines to support hepatitis C virus infection
Journal article
Wilson GK. et al, (2015), Journal of General Virology, 96, 1369 - 1373
Hepatitis C virus infection of cholangiocarcinoma cell lines
Journal article
Fletcher NF. et al, (2015), Journal of General Virology, 96, 1380 - 1388
Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody
Journal article
Mailly L. et al, (2015), Nature Biotechnology, 33, 549 - 554
P0676 : Clearance of persistent hepatitis c virus infection using a monoclonal antibody specific for tight junction protein claudin-1
Conference paper
Mailly L. et al, (2015), Journal of Hepatology, 62, S575 - S575
Structural Flexibility of a Conserved Antigenic Region in Hepatitis C Virus Glycoprotein E2 Recognized by Broadly Neutralizing Antibodies
Journal article
Meola A. et al, (2015), Journal of Virology, 89, 2170 - 2181
Type I interferon rapidly restricts infectious hepatitis C virus particle genesis
Journal article
Meredith LW. et al, (2014), Hepatology, 60, 1891 - 1901
Hypoxia inducible factors in liver disease and hepatocellular carcinoma: Current understanding and future directions
Journal article
Wilson GK. et al, (2014), Journal of Hepatology, 61, 1397 - 1406
Combined Adenovirus Vector and Hepatitis C Virus Envelope Protein Prime-Boost Regimen Elicits T Cell and Neutralizing Antibody Immune Responses
Journal article
Chmielewska AM. et al, (2014), Journal of Virology, 88, 5502 - 5510
The past, present and future of neutralizing antibodies for hepatitis C virus
Journal article
Ball JK. et al, (2014), Antiviral Research, 105, 100 - 111
Polymersome-Mediated Delivery of Combination Anticancer Therapy to Head and Neck Cancer Cells: 2D and 3D in Vitro Evaluation
Journal article
Colley HE. et al, (2014), Molecular Pharmaceutics, 11, 1176 - 1188
P140 MODELLING THE LIVER IMMUNE MICROENVIRONMENT: FACTORS THAT DEFINE ANTIVIRAL ACTIVITY OF T CELLS
Conference paper
Lawrence TM. et al, (2014), Journal of Hepatology, 60, S112 - S113
P206 HEPATITIS C VIRUS COMPARTMENTALISATION: UNRAVELLING GENETIC COMPLEXITY WITHIN THE LIVER
Conference paper
Hedegaard DL. et al, (2014), Journal of Hepatology, 60, S134 - S135
P1265 UNDERSTANDING THE IMPACT OF AGE ON HEPATIC INNATE IMMUNE RESPONSES IN HEPATITIS C VIRUS PATHOGENESIS AND RESPONSE TO INTERFERON THERAPY
Conference paper
Hedegaard DL. et al, (2014), Journal of Hepatology, 60, S511 - S511
P622 MODELLING HCV REPLICATION IN AN INFLAMED LIVER ENVIRONMENT: A NEW ROLE FOR STROMAL EXPRESSED VAP-1 TO REGULATE VIRAL REPLICATION
Conference paper
Galsinh SK. et al, (2014), Journal of Hepatology, 60, S276 - S276
P147 CD4+ T CELL EGRESS THROUGH HEPATIC EPITHELIA HAS PROFOUND IMPLICATIONS FOR PHENOTYPE AND FUNCTION
Conference paper
Niesen D. et al, (2014), Journal of Hepatology, 60, S114 - S115
ctivated macrophages promote hepatitis C virus entry in a tumor necrosis factor-dependent manner
Journal article
Fletcher NF. et al, (2014), Hepatology, 59, 1320 - 1330
P191 HEPATITIS B AND C VIRUS PROMOTE CROSSTALK BETWEEN HYPOXIA AND GLUCOCORTICOID SIGNALLING PATHWAYS TO RE-PROGRAMME HEPATOCYTE METABOLISM AND TO EVADE HOST INTERFERONS
Conference paper
Wilson GK. et al, (2014), Journal of Hepatology, 60, S129 - S130
Role for CD81 and Hepatitis C Virus in Hepatoma Mobility
Journal article
Brimacombe C. et al, (2014), Viruses, 6, 1454 - 1472
IGHV1-69 B Cell Chronic Lymphocytic Leukemia Antibodies Cross-React with HIV-1 and Hepatitis C Virus Antigens as Well as Intestinal Commensal Bacteria
Journal article
Hwang K-K. et al, (2014), PLoS ONE, 9, e90725 - e90725
Paracrine Signals From Liver Sinusoidal Endothelium Regulate Hepatitis C Virus Replication
Journal article
Rowe IA. et al, (2014), Hepatology, 59, 375 - 384
Entry of hepatitis B and C viruses — recent progress and future impact
Journal article
Baumert TF. et al, (2014), Current Opinion in Virology, 4, 58 - 65
Editorial Overview - Virus entry: Towards reality - Refining models of virus entry
Journal article
Marsh M. and McKeating JA., (2014), Current Opinion in Virology, 4, v - vi
Differential effect of p7 inhibitors on hepatitis C virus cell-to-cell transmission
Journal article
Meredith LW. et al, (2013), Antiviral Research, 100, 636 - 639
Viral hepatitis and hepatocellular carcinoma
Journal article
McKeating JA. and Howard CR., (2013), Microbiology Today, 40, 30 - 33
Functional Analysis of Claudin-6 and Claudin-9 as Entry Factors for Hepatitis C Virus Infection of Human Hepatocytes by Using Monoclonal Antibodies
Journal article
Fofana I. et al, (2013), Journal of Virology, 87, 10405 - 10410
n Alpaca Nanobody Inhibits Hepatitis C Virus Entry And Cell-To-Cell Transmission
Journal article
Tarr AW. et al, (2013), Hepatology, 58, 932 - 939
bile acid transporter as a candidate receptor for hepatitis B and D virus entry
Journal article
Xiao F. et al, (2013), Journal of Hepatology, 58, 1246 - 1248
Early infection events highlight the limited transmissibility of hepatitis C virus in vitro
Journal article
Meredith LW. et al, (2013), Journal of Hepatology, 58, 1074 - 1080
Production, Purification and Characterization of Recombinant, Full-Length Human Claudin-1
Journal article
Bonander N. et al, (2013), PLoS ONE, 8, e64517 - e64517
1152 HEPATITIS C VIRUS ENTRY INTO HUMAN HEPATOCYTES IS DEPENDENT ON CLAUDIN-1 BUT NOT ON CLAUDIN-6 AND CLAUDIN-9
Conference paper
Fofana I. et al, (2013), Journal of Hepatology, 58, S468 - S469
58 HRas SIGNAL TRANSDUCTION MEDIATES HEPATITIS C VIRUS CELL ENTRY BY TRIGGERING THE ASSEMBLY OF THE HOST TETRASPANIN RECEPTOR COMPLEX
Conference paper
Zona L. et al, (2013), Journal of Hepatology, 58, S26 - S27
7 T CELLS FACILITATE HEPATITIS C VIRUS TRANSMISSION TO POLARISED LIVER AND BRAIN CELL LINES, REVEALING A NEW ROLE FOR VIRAL QUASISPECIES
Conference paper
Stamataki Z. et al, (2013), Journal of Hepatology, 58, S4 - S4
1178 A NANOBODY RECOGNIZING A NOVEL EPITOPE IN HEPATITIS C VIRUS GLYCOPROTEIN E2 BROADLY NEUTRALIZES VIRUS ENTRY AND INHIBITS CELL–CELL TRANSMISSION
Conference paper
Tarr AW. et al, (2013), Journal of Hepatology, 58, S479 - S479
Hepatoma polarization limitsCD81 and hepatitisCvirus dynamics
Journal article
Harris HJ. et al, (2013), Cellular Microbiology, 15, 430 - 445
HRas Signal Transduction Promotes Hepatitis C Virus Cell Entry by Triggering Assembly of the Host Tetraspanin Receptor Complex
Journal article
Zona L. et al, (2013), Cell Host & Microbe, 13, 302 - 313
Heterogeneous Claudin-1 Expression in Human Liver
Journal article
Harris HJ. et al, (2013), Hepatology, 57, 854 - 855
IFITm1 Is a Tight Junction Protein That Inhibits Hepatitis C Virus Entry
Journal article
Wilkins C. et al, (2013), Hepatology, 57, 461 - 469
Hepatitis C virus kinetics after liver transplantation to study the role of a small molecule inhibitor of viral entry
Conference paper
Rowe IA. et al, (2013), LANCET, 381, 95 - 95
Scavenger receptor B-I antagonist ITX5061 modulates early HCV kinetics in patients undergoing liver transplantation: results of a phase Ib clinical trial
Conference paper
Rowe IA. et al, (2013), HEPATOLOGY, 58, 239A - 239A
In silico directed mutagenesis identifies the CD 81/claudin‐1 hepatitis C virus receptor interface
Journal article
Davis C. et al, (2012), Cellular Microbiology, 14, 1892 - 1903
Hepatitis C Virus Envelope Glycoprotein Fitness Defines Virus Population Composition following Transmission to a New Host
Journal article
Brown RJP. et al, (2012), Journal of Virology, 86, 11956 - 11966
Bioportide: an emergent concept of bioactive cell-penetrating peptides
Journal article
Howl J. et al, (2012), Cellular and Molecular Life Sciences, 69, 2951 - 2966
Hepatitis C virus and the brain
Journal article
Fletcher NF. and McKeating JA., (2012), Journal of Viral Hepatitis, 19, 301 - 306
Hepatitis C virus entry: beyond receptors
Journal article
Meredith LW. et al, (2012), Reviews in Medical Virology, 22, 182 - 193
Hepatitis C Virus Induces CD81 and Claudin-1 Endocytosis
Journal article
Farquhar MJ. et al, (2012), Journal of Virology, 86, 4305 - 4316
dual role for hypoxia inducible factor-1α in the hepatitis C virus lifecycle and hepatoma migration
Journal article
Wilson GK. et al, (2012), Journal of Hepatology, 56, 803 - 809
827 EXPERIMENTAL HCV VACCINE COMBINING ADENOVIRUS AND PROTEIN ELICITS POTENT T-CELL RESPONSES AND NEUTRALIZING ANTIBODIES IN RODENTS
Conference paper
Chmielewska A. et al, (2012), Journal of Hepatology, 56, S323 - S323
Hepatitis C Virus Infects the Endothelial Cells of the Blood-Brain Barrier
Journal article
Fletcher NF. et al, (2012), Gastroenterology, 142, 634 - 643.e6
Naturally Occurring Antibodies That Recognize Linear Epitopes in the Amino Terminus of the Hepatitis C Virus E2 Protein Confer Noninterfering, Additive Neutralization
Journal article
Tarr AW. et al, (2012), Journal of Virology, 86, 2739 - 2749
Over the Fence or Through the Gate: How Viruses Infect Polarized Cells
Journal article
Fletcher NF. et al, (2012), Immunotherapy, 4, 249 - 251
Monoclonal antibodies that target the hepatitis C virus envelope proteins prevent in vivo infection of an escape variant isolated from a liver transplant patient
Conference paper
Fafi-Kremer S. et al, (2012), HEPATOLOGY, 56, 237A - 237A
HRas is a host factor for hepatitis C virus entry acting as a switch for CD81-claudin1 co-receptor associations
Conference paper
Lupberger J. et al, (2012), HEPATOLOGY, 56, 219A - 220A
HCV entry in primary human hepatocytes is claudin-6 and claudin-9 independent
Conference paper
Fofana I. et al, (2012), HEPATOLOGY, 56, 714A - 715A
Rituximab Treatment in Hepatitis C Infection: An In Vitro Model to Study the Impact of B Cell Depletion on Virus Infectivity
Journal article
Stamataki Z. et al, (2011), PLoS ONE, 6, e25789 - e25789
Immunization of Human Volunteers With Hepatitis C Virus Envelope Glycoproteins Elicits Antibodies That Cross-Neutralize Heterologous Virus Strains
Journal article
Stamataki Z. et al, (2011), The Journal of Infectious Diseases, 204, 811 - 813
P97 Lymphocyte-hepatocyte interactions: hepatitis C virus changes the rules
Conference paper
Stamataki Z. et al, (2011), Gut, 60, A45.2 - A45
Hepatitis C virus targets the T cell secretory machinery as a mechanism of immune evasion
Journal article
Petrovic D. et al, (2011), Hepatology, 53, 1846 - 1853
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy
Journal article
Lupberger J. et al, (2011), Nature Medicine, 17, 589 - 595
Structural characterization of CD81–Claudin-1 hepatitis C virus receptor complexes
Journal article
Bonander N. et al, (2011), Biochemical Society Transactions, 39, 537 - 540
Hepatitis C virus entry and the tetraspanin CD81
Journal article
Farquhar MJ. et al, (2011), Biochemical Society Transactions, 39, 532 - 536
1374 LYMPHOCYTE-HEPATOCYTE INTERACTIONS: HEPATITIS C VIRUS CHANGES THE RULES
Conference paper
Stamataki Z. et al, (2011), Journal of Hepatology, 54, S545 - S545
Neutralizing Antibody-Resistant Hepatitis C Virus Cell-to-Cell Transmission
Journal article
Brimacombe CL. et al, (2011), Journal of Virology, 85, 596 - 605
Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors
Journal article
Syder AJ. et al, (2011), Journal of Hepatology, 54, 48 - 55
Hepatitis C Virus Glycoprotein-dependent Entry
Chapter
Drummer HE. and McKeating JA., (2011), 321 - 343
Lymphocyte interactions with hepatocytes: distinct mechanisms for T and B cells
Conference paper
Stamataki Z. et al, (2011), IMMUNOLOGY, 135, 132 - 132
IDENTIFICATION OF EGFR SIGNALLING PATHWAYS MEDIATING HEPATITIS C VIRUS ENTRY
Conference paper
Lupberger J. et al, (2011), HEPATOLOGY, 54, 420A - 420A
Hepatitis C Virus Infection of Neuroepithelioma Cell Lines
Journal article
Fletcher NF. et al, (2010), Gastroenterology, 139, 1365 - 1374.e2
Monoclonal Anti-Claudin 1 Antibodies Prevent Hepatitis C Virus Infection of Primary Human Hepatocytes
Journal article
Fofana I. et al, (2010), Gastroenterology, 139, 953 - 964.e4
Mechanisms of viral entry: sneaking in the front door
Journal article
Thorley JA. et al, (2010), Protoplasma, 244, 15 - 24
Claudin Association with CD81 Defines Hepatitis C Virus Entry
Journal article
Harris HJ. et al, (2010), Journal of Biological Chemistry, 285, 21092 - 21102
Multiple Effects of Silymarin on the Hepatitis C Virus Lifecycle
Journal article
Wagoner J. et al, (2010), Hepatology, 51, 1912 - 1921
Development of novel therapies for hepatitis C
Journal article
Lemon SM. et al, (2010), Antiviral Research, 86, 79 - 92
Inhibition of hepatitis C virus infection by anti‐claudin‐1 antibodies is mediated by neutralization of E2–CD81–Claudin‐1 associations†
Journal article
Krieger SE. et al, (2010), Hepatology, 51, 1144 - 1157
Hepatitis C Virus Infection Reduces Hepatocellular Polarity in a Vascular Endothelial Growth Factor–Dependent Manner
Journal article
Mee CJ. et al, (2010), Gastroenterology, 138, 1134 - 1142
The Involvement of Tight Junction Protein Claudin-1 in Hepatitis C Virus Entry
Book
(2010), 273 - 292
CENTRAL ROLE OF TIGHT JUNCTION PROTEINS FOR CELL-CELL TRANSMISSION AND DISSEMINATION OF HEPATITIS C VIRUS
Conference paper
Xiao F. et al, (2010), HEPATOLOGY, 52, 339A - 339A
TARGETING HEPATOCYTE RECEPTOR TYROSINE KINASES BY ERLOTINIB AND INHIBITION OF HEPATITIS C VIRUS INFECTION IN VIVO
Conference paper
Lupberger J. et al, (2010), HEPATOLOGY, 52, 1207A - 1207A
Development of novel therapies for hepatitis C
Journal article
Lemon SM. et al, (2010), ANTIVIRAL RESEARCH, 86, 79 - 92
Hepatoma Cell Density Promotes Claudin-1 and Scavenger Receptor BI Expression and Hepatitis C Virus Internalization
Journal article
Schwarz AK. et al, (2009), Journal of Virology, 83, 12407 - 12414
The complexities of hepatitis C virus entry
Journal article
Balfe P. and McKeating JA., (2009), Journal of Hepatology, 51, 609 - 611
Mutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus Infectivity
Journal article
Keck Z-Y. et al, (2009), Journal of Virology, 83, 6149 - 6160
Polarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma Cells
Journal article
Mee CJ. et al, (2009), Journal of Virology, 83, 6211 - 6221
Hepatitis C virus association with peripheral blood B lymphocytes potentiates viral infection of liver-derived hepatoma cells
Journal article
Stamataki Z. et al, (2009), Blood, 113, 585 - 593
Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies
Journal article
Grove J. et al, (2008), Journal of Virology, 82, 12020 - 12029
In vitro selection of a neutralization-resistant hepatitis C virus escape mutant
Journal article
Gal-Tanamy M. et al, (2008), Proceedings of the National Academy of Sciences, 105, 19450 - 19455
Primary hepatocytes as targets for Hepatitis C virus replication
Journal article
Farquhar MJ. and McKeating JA., (2008), Journal of Viral Hepatitis, 15, 849 - 854
Hepatitis C virus entry: possible targets for therapy
Journal article
Timpe JM. and McKeating JA., (2008), Gut, 57, 1728 - 1737
Protein Kinase A-Dependent Step(s) in Hepatitis C Virus Entry and Infectivity
Journal article
Farquhar MJ. et al, (2008), Journal of Virology, 82, 8797 - 8811
Hepatitis C Virus Entry and Neutralization
Journal article
Stamataki Z. et al, (2008), Clinics in Liver Disease, 12, 693 - 712
Hepatitis C Virus (HCV)–Specific Immune Responses of Long‐Term Injection Drug Users Frequently Exposed to HCV
Journal article
Mizukoshi E. et al, (2008), The Journal of Infectious Diseases, 198, 203 - 212
CD81 and Claudin 1 Coreceptor Association: Role in Hepatitis C Virus Entry
Journal article
Harris HJ. et al, (2008), Journal of Virology, 82, 5007 - 5020
Structural characterization of recombinant human CD81 produced in Pichia pastoris
Journal article
Jamshad M. et al, (2008), Protein Expression and Purification, 57, 206 - 216
Hepatitis C virus receptor expression in normal and diseased liver tissue
Journal article
Reynolds GM. et al, (2008), Hepatology, 47, 418 - 427
Serum-Derived Hepatitis C Virus Infection of Primary Human Hepatocytes Is Tetraspanin CD81 Dependent
Journal article
Molina S. et al, (2008), Journal of Virology, 82, 569 - 574
Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies
Journal article
Timpe JM. et al, (2008), Hepatology, 47, 17 - 24
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge
Journal article
Law M. et al, (2008), Nature Medicine, 14, 25 - 27
Effect of Cell Polarization on Hepatitis C Virus Entry
Journal article
Mee CJ. et al, (2008), Journal of Virology, 82, 461 - 470
Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies
Journal article
Stamataki Z. et al, (2007), Vaccine, 25, 7773 - 7784
Hepatitis C is associated with perturbation of intrahepatic myeloid and plasmacytoid dendritic cell function.
Journal article
Lai WK. et al, (2007), Journal of hepatology, 47, 338 - 347
The neutralizing activity of anti-hepatitis C virus antibodies is modulated by specific glycans on the E2 envelope protein.
Journal article
Helle F. et al, (2007), Journal of virology, 81, 8101 - 8111
Superinfection Exclusion in Cells Infected with Hepatitis C Virus
Journal article
Tscherne DM. et al, (2007), Journal of Virology, 81, 3693 - 3703
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
Journal article
Evans MJ. et al, (2007), Nature, 446, 801 - 805
Scavenger Receptor BI and BII Expression Levels Modulate Hepatitis C Virus Infectivity
Journal article
Grove J. et al, (2007), Journal of Virology, 81, 3162 - 3169
In vitro veritas? The challenges of studying hepatitis C virus infectivity in a test tube
Journal article
von Hahn T. and McKeating JA., (2007), Journal of Hepatology, 46, 355 - 358
Discordant Role of CD4 T-Cell Response Relative to Neutralizing Antibody and CD8 T-Cell Responses in Acute Hepatitis C
Journal article
Kaplan DE. et al, (2007), Gastroenterology, 132, 654 - 666
Hepatitis C Virus Continuously Escapes From Neutralizing Antibody and T-Cell Responses During Chronic Infection In Vivo
Journal article
von Hahn T. et al, (2007), Gastroenterology, 132, 667 - 678
Hepatitis C virus and alanine aminotransferase kinetics following B-lymphocyte depletion with rituximab: evidence for a significant role of humoral immunity in the control of viremia in chronic HCV liver disease
Journal article
Lake-Bakaar G. et al, (2007), Blood, 109, 845 - 846
Initiation of Hepatitis C Virus Infection Is Dependent on Cholesterol and Cooperativity between CD81 and Scavenger Receptor B Type I
Journal article
Kapadia SB. et al, (2007), Journal of Virology, 81, 374 - 383
Diverse CD81 Proteins Support Hepatitis C Virus Infection
Journal article
Flint M. et al, (2006), Journal of Virology, 80, 11331 - 11342
Persistent Hepatitis C Virus Infection In Vitro: Coevolution of Virus andHost
Journal article
Zhong J. et al, (2006), Journal of Virology, 80, 11082 - 11093
Expression of DC-SIGN and DC-SIGNR on Human Sinusoidal Endothelium
Journal article
Lai WK. et al, (2006), The American Journal of Pathology, 169, 200 - 208
Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells
Journal article
von Hahn T. et al, (2006), Hepatology, 43, 932 - 942
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
Journal article
Lindenbach BD. et al, (2006), Proceedings of the National Academy of Sciences, 103, 3805 - 3809
Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus.
Journal article
Rouillé Y. et al, (2006), Journal of virology, 80, 2832 - 2841
Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry
Journal article
Tscherne DM. et al, (2006), Journal of Virology, 80, 1734 - 1741
Identification of claudin-1 as an essential cellular cell entry factor for hepatitis C virus
Conference paper
von Hahn T. et al, (2006), HEPATOLOGY, 44, 197A - 197A
Humoral immune response in acute hepatitis C virus infection.
Journal article
Netski DM. et al, (2005), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 41, 667 - 675
Complete Replication of Hepatitis C Virus in Cell Culture
Journal article
Lindenbach BD. et al, (2005), Science, 309, 623 - 626
daptive T cell response in acute hepatitis C
Conference paper
Kaplan DE. et al, (2005), HEPATOLOGY, 42, 545A - 545A
Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent Manner
Journal article
McKeating JA. et al, (2004), Journal of Virology, 78, 8496 - 8505
Neutralizing antibody response during acute and chronic hepatitis C virus infection
Journal article
Logvinoff C. et al, (2004), Proceedings of the National Academy of Sciences, 101, 10149 - 10154
Characterization of Infectious Retroviral Pseudotype Particles Bearing Hepatitis C Virus Glycoproteins
Journal article
Flint M. et al, (2004), Journal of Virology, 78, 6875 - 6882
CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection
Journal article
Zhang J. et al, (2004), Journal of Virology, 78, 1448 - 1455
Comparison of nucleic acid and protein immunization for induction of antibodies specific for HIV-1 gp120
Journal article
PEET NM. et al, (2003), Clinical and Experimental Immunology, 109, 226 - 232
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles
Journal article
Hsu M. et al, (2003), Proceedings of the National Academy of Sciences, 100, 7271 - 7276
Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR
Journal article
Pöhlmann S. et al, (2003), Journal of Virology, 77, 4070 - 4080
Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell Culture
Journal article
Blight KJ. et al, (2003), Journal of Virology, 77, 3181 - 3190
Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2.
Journal article
Roccasecca R. et al, (2003), Journal of virology, 77, 1856 - 1867
Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication
Journal article
Blight KJ. et al, (2002), Journal of Virology, 76, 13001 - 13014
Truncated gp120 envelope glycoprotein of human immunodeficiency virus 1 elicits a broadly reactive neutralizing immune response
Journal article
Jeffs SA. et al, (2002), Journal of General Virology, 83, 2723 - 2732
Pharmacological characterization of the chemokine receptor, CCR5
Journal article
Mueller A. et al, (2002), British Journal of Pharmacology, 135, 1033 - 1043
Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2
Journal article
Owsianka A. et al, (2001), Journal of General Virology, 82, 1877 - 1883
ntigenic Variation within the CD4 Binding Site of Human Immunodeficiency Virus Type 1 gp120: Effects on Chemokine Receptor Utilization
Journal article
Hammond AL. et al, (2001), Journal of Virology, 75, 5593 - 5603
non-Hodgkin's lymphoma immunoglobulin binds to the envelope 2 (E2) glycoprotein of hepatitis C virus
Conference paper
Quinn ER. et al, (2001), FASEB JOURNAL, 15, A310 - A310
Pharmacological analysis of CCR5 receptors using [35S]-GTPγS binding
Conference paper
Mahmoud NG. et al, (2001), BRITISH JOURNAL OF PHARMACOLOGY, 133, U99 - U99
Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding
Journal article
Patel AH. et al, (2000), Journal of General Virology, 81, 2873 - 2883
Hepatitis C Virus Glycoprotein E2 Binding to CD81: The Role of E1E2 Cleavage and Protein Glycosylation in Bioactivity
Journal article
Chan-Fook C. et al, (2000), Virology, 273, 60 - 66
Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection.
Journal article
Meola A. et al, (2000), Journal of virology, 74, 5933 - 5938
Identification of Amino Acid Residues in CD81 Critical for Interaction with Hepatitis C Virus Envelope Glycoprotein E2
Journal article
Higginbottom A. et al, (2000), Journal of Virology, 74, 3642 - 3649
The role of the hepatitis C virus glycoproteins in infection
Journal article
Flint M. and McKeating JA., (2000), Reviews in Medical Virology, 10, 101 - 117
Functional Characterization of Intracellular and Secreted Forms of a Truncated Hepatitis C Virus E2 Glycoprotein
Journal article
Flint M. et al, (2000), Journal of Virology, 74, 702 - 709
The C-terminal region of the hepatitis C virus E1 glycoprotein confers localization within the endoplasmic reticulum
Journal article
Flint M. and McKeating JA., (1999), Journal of General Virology, 80, 1943 - 1947
Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81.
Journal article
Flint M. et al, (1999), Journal of virology, 73, 6235 - 6244
Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein.
Journal article
Flint M. et al, (1999), Journal of virology, 73, 6782 - 6790
Identification of Amino Acid Residues Critical for Aggregation of Human CC Chemokines Macrophage Inflammatory Protein (MIP)-1α, MIP-1β, and RANTES
Journal article
Czaplewski LG. et al, (1999), Journal of Biological Chemistry, 274, 16077 - 16084
Shorter Survival in Advanced Human Immunodeficiency Virus Type 1 Infection Is More Closely Associated with T Lymphocyte Activation than with Plasma Virus Burden or Virus Chemokine Coreceptor Usage
Journal article
Giorgi JV. et al, (1999), The Journal of Infectious Diseases, 179, 859 - 870
The role of the viral glycoprotein in HIV-1 persistence
Journal article
McKeating JA. and Balfe P., (1999), Immunology Letters, 65, 63 - 70
The Effect of Low-Profile Serine Substitutions in the V3 Loop of HIV-1 gp120 IIIB/LAI on the Immunogenicity of the Envelope Protein
Journal article
Peet NM. et al, (1998), Virology, 251, 59 - 70
Development of a neutralizing antibody response during acute primary human immunodeficiency virus type 1 infection and the emergence of antigenic variants.
Journal article
Lewis J. et al, (1998), Journal of virology, 72, 8943 - 8951
ssociation between a Defective CCR-5 Gene and Progression to Disease in HIV Infection
Journal article
BALFE P. et al, (1998), AIDS Research and Human Retroviruses, 14, 1229 - 1234
Passage of HIV-1 Molecular Clones into Different Cell Lines Confers Differential Sensitivity to Neutralization
Journal article
Zhang Y-J. et al, (1997), Virology, 238, 254 - 264
Mutant CD4 molecules with improved binding to HIV envelope protein gp120 selected by phage display.
Journal article
Krykbaev R. et al, (1997), Virology, 234, 196 - 202
Regulated expression vectors demonstrate cell-type-specific sensitivity to human immunodeficiency virus type 1 Nef-induced cytostasis.
Journal article
Cooke SJ. et al, (1997), Journal of General Virology, 78, 381 - 392
Length polymorphism within the second variable region of the human immunodeficiency virus type 1 envelope glycoprotein affects accessibility of the receptor binding site.
Journal article
Fox DG. et al, (1997), Journal of virology, 71, 759 - 765
Prevalence of a V2 epitope in clade B primary isolates and its recognition by sera from HIV-1-infected individuals.
Journal article
Israel ZR. et al, (1997), AIDS (London, England), 11, 128 - 130
Biological consequences of human immunodeficiency virus type 1 envelope polymorphism: does variation matter?: 1995 Fleming Lecture Delivered at the 134th Meeting of the Society for General Microbiology, 26 March 1996
Journal article
McKeating JA., (1996), Journal of General Virology, 77, 2905 - 2919
Immunogenicity of full length and truncated forms of the human immunodeficiency virus type I envelope glycoprotein
Journal article
McKeating JA. et al, (1996), Immunology Letters, 51, 101 - 105
Functional Characterization of the V1V2 Region of Human Immunodeficiency Virus Type I
Journal article
PALMER C. et al, (1996), Virology, 220, 436 - 449
Chimeric Viruses Expressing Primary Envelope Glycoproteins of Human Immunodeficiency Virus Type I Show Increased Sensitivity to Neutralization by Human Sera
Journal article
MCKEATING JA. et al, (1996), Virology, 220, 450 - 460
Identification and characterization of monoclonal antibodies specific for polymorphic antigenic determinants within the V2 region of the human immunodeficiency virus type 1 envelope glycoprotein.
Journal article
Shotton C. et al, (1995), Journal of virology, 69, 222 - 230
THE FIRST AND 2ND VARIABLE REGIONS OF HIV-1 GP120 AFFECT THE ABILITY OF THE ENVELOPE GLYCOPROTEIN TO BIND CD4
Conference paper
FOX D. et al, (1995), AIDS RESEARCH AND HUMAN RETROVIRUSES, 11, S104 - S104
Expression of HIV-1 Envelope Glycoproteins by Semliki Forest Virus Vectors
Journal article
PAUL NL. et al, (1993), AIDS Research and Human Retroviruses, 9, 963 - 970
n Immune-Selected Point Mutation in the Transmembrane Protein of Human Immunodeficiency Virus Type 1 (HXB2-Env:Ala 582(→ Thr)) Decreases Viral Neutralization by Monoclonal Antibodies to the CD4-Binding Site
Journal article
Klasse PJ. et al, (1993), Virology, 196, 332 - 337
Resistance of a human serum-selected human immunodeficiency virus type 1 escape mutant to neutralization by CD4 binding site monoclonal antibodies is conferred by a single amino acid change in gp120.
Journal article
McKeating JA. et al, (1993), Journal of virology, 67, 5216 - 5225
Characterization of neutralizing monoclonal antibodies to linear and conformation-dependent epitopes within the first and second variable domains of human immunodeficiency virus type 1 gp120.
Journal article
McKeating JA. et al, (1993), Journal of virology, 67, 4932 - 4944
Soluble CD4 and CD4 Immunoglobulin-Selected HIV-1 Variants: A Phenotypic Characterization
Journal article
KLASSE PJ. and McKEATING JA., (1993), AIDS Research and Human Retroviruses, 9, 595 - 604
Further characterization of an antigenic site of HIV-I gp120 recognized by virus neutralizing human monoclonal anti bodies
Journal article
Schutten M. et al, (1993), AIDS, 7, 919 - 924
CHARACTERIZATION OF A HUMAN SERUM SELECTED HIV-1 ESCAPE MUTANT RESISTANT TO NEUTRALIZATION BY MONOCLONAL-ANTIBODIES MAPPING TO THE CD4 BINDING-SITE OF GP120
Conference paper
MCKEATING JA. et al, (1993), AIDS RESEARCH AND HUMAN RETROVIRUSES, 9, S100 - S100
Synergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type I gpl20
Journal article
McKeating JA. et al, (1992), Virology, 191, 732 - 742
mino acid residues of the human immunodeficiency virus type I gp120 critical for the binding of rat and human neutralizing antibodies that block the gp120-sCD4 interaction
Journal article
McKeating JA. et al, (1992), Virology, 190, 134 - 142
Vaginal immunization of rats with a synthetic peptide from human immunodeficiency virus envelope glycoprotein
Journal article
O'Hagan DT. et al, (1992), Journal of General Virology, 73, 2141 - 2145
CPF-DD is an inhibitor of infection by human immunodeficiency virus and other enveloped viruses in vitro
Journal article
Moore JP. et al, (1992), Virology, 188, 537 - 544
CD4 antagonists
Journal article
McKeating JA., (1992), Biochemical Society Transactions, 20, 521 - 525
Monoclonal Antibodies to the C4 Region of Human Immunodeficiency Virus Type 1 gp120: Use in Topological Analysis of a CD4 Binding Site
Journal article
McKEATING JA. et al, (1992), AIDS Research and Human Retroviruses, 8, 451 - 459
Neutralization of human immunodeficiency virus
Journal article
Mckeating JA., (1992), Reviews in Medical Virology, 2, 35 - 42
Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates.
Journal article
Moore JP. et al, (1992), Journal of virology, 66, 235 - 243
EXTENT AND RATE OF INACTIVATION OF CLONAL AND HETEROGENEOUS HIV-1 BY SOLUBLE CD4 AND CD4 IMMUNOADHESIN
Conference paper
KLASSE PJ. et al, (1992), AIDS RESEARCH AND HUMAN RETROVIRUSES, 8, 906 - 906
VIRIONS FROM PRIMARY HIV-1 ISOLATES RESISTANT TO SCD4 NEUTRALIZATION HAVE REDUCED SCD4 AFFINITY BUT RETAIN GP120 AFTER SCD4 BINDING
Conference paper
MOORE JP. et al, (1992), AIDS RESEARCH AND HUMAN RETROVIRUSES, 8, 906 - 906
Rat monoclonal antibodies to nonoverlapping epitopes of human immunodeficiency virus type 1 gp120 block CD4 binding in Vitro
Journal article
Cordell J. et al, (1991), Virology, 185, 72 - 79
Recombinant CD4-selected human immunodeficiency virus type 1 variants with reduced gp120 affinity for CD4 and increased cell fusion capacity.
Journal article
McKeating J. et al, (1991), Journal of virology, 65, 4777 - 4785
Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implications for virus-cell binding and fusion reactions and their neutralization by soluble CD4.
Journal article
Moore JP. et al, (1991), Journal of virology, 65, 1133 - 1140
Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization.
Journal article
McKeating JA. et al, (1991), Journal of virology, 65, 852 - 860
The V3 Loops of the HIV-1 and HTV-2 Surface Glycoproteins Contain Proteolytic Cleavage Sites: A Possible Function in Viral Fusion?
Journal article
CLEMENTS GJ. et al, (1991), AIDS Research and Human Retroviruses, 7, 3 - 16
Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody.
Journal article
Ho DD. et al, (1991), Journal of virology, 65, 489 - 493
HIV-1 neutralization directed to epitopes other than linear V3 determinants.
Journal article
Steimer KS. et al, (1991), AIDS (London, England), 5 Suppl 2, S135 - S143
CONFORMATIONAL GP120 NEUTRALIZATION EPITOPES ON HIV-1
Conference paper
MCKEATING JA., (1991), 6TH CENT GARDES MEETING, 199 - 202
SOLUBLE CD4 BINDING TO HIV-1 VIRIONS CAUSES GP120 TO DISSOCIATE FROM GP41
Conference paper
MOORE JP. et al, (1991), VACCINES 91, 59 - 63
Dissociation of gp120 from HIV-1 Virions Induced by Soluble CD4
Journal article
Moore JP. et al, (1990), Science, 250, 1139 - 1142
Characterization of recombinant gp120 and gp160 from HIV-1
Journal article
Moore JP. et al, (1990), AIDS, 4, 307 - 316
HIV susceptibility conferred to human fibroblasts by cytomegalovirus-induced Fc receptor
Journal article
McKeating JA. et al, (1990), Nature, 343, 659 - 661
Tumour necrosis factors (α, β) induced by HIV-1 in peripheral blood mononuclear cells potentiate virus replication
Journal article
Vyakarnam A. et al, (1990), AIDS, 4, 21 - 28
ntigenic variation in HIV.
Journal article
Putney SD. and McKeating JA., (1990), AIDS (London, England), 4 Suppl 1, S129 - S136
HIV TARGET-CELL INTERACTIONS
Conference paper
WEISS RA. et al, (1990), AIDS RESEARCH AND HUMAN RETROVIRUSES, 6, 1358 - 1358
Characterization of HIV-1 neutralization escape mutants
Journal article
McKeating JA. et al, (1989), AIDS, 3, 777 - 784
Evaluation of Human and Simian Immunodeficiency Virus Plaque and Neutralization Assays
Journal article
McKeating JA. et al, (1989), Journal of General Virology, 70, 3327 - 3333
n enzyme-linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1
Journal article
Moore JP. et al, (1989), Aids, 3, 155 - 164
Structure and function of the HIV envelope
Journal article
McKeating JA. and Willey RL., (1989), Aids, 3, S35 - 42
Inoculation of New World primates with the human immunodeficiency virus.
Journal article
McClure MO. et al, (1989), Journal of medical primatology, 18, 329 - 335
THE ROLE OF CD4 ANTIGEN IN HIV INFECTION
Conference paper
WEISS RA. et al, (1989), PROGRESS IN IMMUNOLOGY, VOL 7, 1021 - 1027
Identification of a monoclonal antibody to abscission tissue that recognises xylose/fucose-containing N-linked oligosaccharides from higher plants.
Journal article
McManus MT. et al, (1988), Planta, 175, 506 - 512
Enhancement of class I HLA antigen expression by cytomegalovirus: Role in amplification of virus infection
Journal article
Grundy JE. et al, (1988), Journal of Medical Virology, 25, 483 - 495
CYTOMEGALOVIRUS AND β2 MICROGLOBULIN IN URINE SPECIMENS
Journal article
GRUNDY JE. et al, (1988), Transplantation, 45, 1075 - 1079
Human immunodeficiency viruses: neutralization and receptors.
Journal article
Weiss RA. et al, (1988), Journal of acquired immune deficiency syndromes, 1, 536 - 541
beta2 Microglobulin Enhances the Infectivity of Cytomegalovirus and When Bound to the Virus Enables Class I HLA Molecules To Be Used as a Virus Receptor
Journal article
Grundy JE. et al, (1987), Journal of General Virology, 68, 793 - 803
Cytomegalovirus Strain AD169 Binds beta2 Microglobulin in Vitro after Release from Cells
Journal article
Grundy JE. et al, (1987), Journal of General Virology, 68, 777 - 784
Cytomegalovirus in Urine Specimens Has Host beta2 Microglobulin Bound to the Viral Envelope: A Mechanism of Evading the Host Immune Response?
Journal article
McKeating JA. et al, (1987), Journal of General Virology, 68, 785 - 792
Detection of cytomegalovirus by ELISA in urine samples is inhibited by β2 microglobulin
Journal article
McKeating JA. et al, (1986), Journal of Medical Virology, 18, 341 - 348
Detection of cytomegalovirus in urine samples by enzyme‐linked immunosorbent assay
Journal article
McKeating JA. et al, (1985), Journal of Medical Virology, 16, 367 - 373
Detection of cytomegalovirus by DNA-DNA hybridization employing probes labelled with 32-phosphorus or biotin
Journal article
Mckeating JA. et al, (1985), Journal of Virological Methods, 11, 207 - 216